Category: News

Alacris Theranostics: Tomorrow Today with Alacris Theranostics

Dr. Alexander Kühn, Head of Modeling, Alacris Theranostics GmbH, was invited for a studio discussion for the science magazine Tomorrow Today of Deutsche Welle. Here he talked about whether information technology can help make the world healthier, and what role is played by the virtual patient. Watch the video here:

Read More

Alacris Theranostics enters agreement with GSK to use ModCellTM System for early stage cancer research

Berlin, 14th November 2012 – Alacris Theranostics has entered into an agreement with GlaxoSmithKline (GSK) to apply Alacris’ proprietary ModCell™ System, developed at the Max Planck Institute for Molecular Genetics and licensed exclusively to Alacris, for drug stratification using data from early stage cancer drug discovery at GSK. GSK will provide to Alacris pre-clinical biology […]

Read More

QIAGEN to acquire stake in Alacris

QIAGEN has signed an agreement for the acquisition of  a strategic stake in Alacris Theranostics GmbH, a German start-up company using the novel technology ModCellTM to develop individualized cancer treatment strategies based upon a patient’s genomic profile, and for the acquisition of an exclusive option to access all biomarkers emerging from this discovery program.  The […]

Read More